Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Laura Wueste

Nurse Practitioner, Acute Care Houston, TX Nurse Practitioner

NPI 1639461379 CMS profile 11169844

1631 North Loop W, Suite 240 Pob 1, Houston, TX 77001

Open in the dashboard

General payments

$10,506

95 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Laura Wueste of Houston, TX is reported in the CMS Open Payments database as having received $10,506 across 95 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner, Acute Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,323 24
2024 General $2,132 21
2023 General $3,398 21
2022 General $2,126 22
2021 General $528 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Laura Wueste
  • Nurse Practitioner, Acute Care median
  • Middle half of Nurse Practitioner, Acute Care
  • National median

In program year 2025, general payments to Laura Wueste were reported at $2,323. Among 11,827 Nurse Practitioner, Acute Care profiles paid that year, the median was $152 and the middle half received between $48 and $458.

Show as a table
Year Laura Wueste Nurse Practitioner, Acute Care median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $528 $123 $38–$327 $132
2022 $2,126 $130 $44–$369 $149
2023 $3,398 $144 $49–$410 $160
2024 $2,132 $146 $48–$433 $164
2025 $2,323 $152 $48–$458 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Abiomed $4,075 25 payments
  2. Edwards Lifesciences Corporation $1,771 12 payments
  3. Abbott Laboratories $788 10 payments
  4. Atricure, Inc. $766 5 payments
  5. Amgen Inc. $608 12 payments
  6. Shockwave Medical, Inc $529 4 payments
  7. Boston Scientific Corporation $428 4 payments
  8. Janssen Pharmaceuticals, Inc $413 7 payments
  9. Medtronic, Inc. $359 4 payments
  10. Biotronik Inc. $160 1 payment
  11. Other $609 11 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,526 88 payments
  2. Travel and Lodging $2,980 7 payments
Products named General payments · program years 2021–2025
  1. Impella $3,440 15 payments
  2. Repatha $608 12 payments
  3. AtriCure cryoICE cryoSPHERE Cryoablation System $461 3 payments
  4. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $454 3 payments
  5. XARELTO $413 7 payments
  6. SYNERGY ABLATION SYSTEM $402 3 payments
  7. MITRACLIP Vascular $339 5 payments
  8. ATRICLIP LAA EXCLUSION SYSTEM $269 2 payments
  9. MITRACLIP Structural Heart $255 2 payments
  10. HemoSphere $244 3 payments
  11. Other $2,570 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

95 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Acute Care in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record